MiNK Therapeutics (6Q40.F) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.91
-0.75
-0.6
-0.44

Details

Expected EPS
-0.46923708612000004
Actual EPS
-0.9098616
Surprise EPS
-0.44
Surprise Percent
+93.9%

Description

MiNK Therapeutics (6Q40.F) has reported earnings of -0.9098616 per share for Q3 2025.

0 Comments

Share your thoughts